Beyond The Robot: How Depuy Synthes Is Developing Personalized Digital Solutions For The Asian Patient

Monday, June 17, 2019

DePuy Synthes,* part of the Johnson & Johnson Medical Devices Companies,** brought together an international consortium of orthopaedic surgeons to devise a plan for developing a first-of-its-kind ecosystem of digital solutions for Asian patients undergoing total knee arthroplasty (TKA).

DePuy Synthes recognizes that every knee is different; Asian patients have their own unique set of needs, particularly in TKA. Factors including Asian patients’ bone morphology and disease state differ from the West, significantly impacting the demands of TKA implant design. As highlighted during the meeting, the incidence of inherent varus, or oblique limb deformity, is nearly 10% higher in Asian populations than Western, putting increased stress on the tibial surface.1-2

Studies have also found that the average Asian patient tends to be older than Western patients at the time of diagnosis and surgery. For example, the average knee patient is nearly six years older in Japan than in the West.3-4 This further substantiates a significant need for solutions that address the sensitivities of these patients in pre- and post-op stages. Other lifestyle factors further impact the expected functionality of an Asian patient’s implant. For instance, the average pronounced tibial slope in an Asian knee is 11º compared to a Western knee which is typically 6.9º, requiring the implant to have greater flexion.5

“In an era when many companies are looking at robotics as the solution, we see them as only part of the solution – one that puts the patient at the centre,” said Mayank Shandil, Senior Director, Joints Marketing, DePuy Synthes, Asia Pacific. “We must go beyond the robot and develop an integrated digital surgery ecosystem, rooted in predictive data analytics, that addresses the unique needs of Asian patients and keeps them moving.”

Machine learning, artificial intelligence and cloud-based technologies are only as powerful as the data being processed. As DePuy Synthes seeks to bring an end-to-end system of digital solutions for the Asian patient, datasets must be representative of this part of the world’s population. This was a key point of discussion amongst orthopaedic surgeons at the meeting, held at the company’s Tokyo Science Centre.

“In order to truly be patient-centric, we must think about the digital solutions being utilised from a patient’s very first consultation through their surgery and recovery process,” said Sushobhan Dasgupta, Vice President of Orthopaedics, Johnson & Johnson Medical Devices Companies Asia Pacific. “Our next step in bringing these tools to scale in Asia Pacific is building a dataset that reflects our patients in this region. This will enable us to deliver an ecosystem of solutions that truly support surgeons and patients in Asia and beyond.

The group of orthopaedic surgeons will reconvene with DePuy Synthes in early October.

About DePuy Synthes

DePuy Synthes, part of Johnson & Johnson Medical Devices Companies, provides one of the most comprehensive orthopedics portfolios in the world. DePuy Synthes solutions, in specialties including joint reconstruction, trauma, craniomaxillofacial, spinal surgery and sports medicine, are designed to advance patient care while delivering clinical and economic value to health care systems worldwide. For more information, visit www.depuysynthes.com.

About Johnson & Johnson Medical Devices Companies

As the world’s most comprehensive medical devices business, we are building on a century of experience, merging science and technology, to shape the future of health and benefit even more people around the world. With our unparalleled breadth, depth and reach across surgery, orthopaedics, vision and interventional solutions, we’re working to profoundly change the way care is delivered. We are in this for life.

Cautionary Statements

This press release contains "forward-looking statements" as defined in the Private Securities Litigation Reform Act of 1995 regarding, among other things, future operating and financial performance, product development, regulatory approvals, market position, expenditures, impact of acquisitions and dispositions, business strategy and restructuring plans. These statements use words, and variations of words, such as "will," "plan," "expect," "anticipate," "estimate," "next," "project," "potential," "continue," "expand" and "grow". You are cautioned not to rely on these forward-looking statements. These statements are based on current assumptions and expectations of future events at the time they are made and thus are inherently subject to uncertainty.

*DePuy Synthes represents the products and services of DePuy Synthes, Inc. and its affiliates.
**The Johnson & Johnson Medical Devices Companies comprise the surgery, orthopaedics, and cardiovascular businesses within Johnson & Johnson’s Medical Devices segment.

MEDIA CONTACT:
Toneisha Friday
+65 8218 1073
tfriday3@its.jnj.com

1 Liu HX. Shorter survival rates in varus-aligned knees after total knee arthroplasty. 2016.
2 Ritter MA. Total knee arthroplasty in patients with angular varus or valgus deformities of > or = 20 degrees. 2004.
3 Elizabeth W. Paxton, JBJS, 2011.
4 Data from Social Insurance Agency, 2008.
5 Chiu KY, Zhang SD, Zhang GH. Posterior slope of tibial plateau in Chinese. J Arthroplasty 2000;15:224e7.